India, Netherlands sign MoU for vaccine development

  • Posted on: 15 June 2015
  • By: Shalini.Sharma

 

Under “Make in India” initiative India and the Netherlands have signed a Memorandum of Understanding  for the development of vaccines. The MoU was signed between visiting Prime Minister of Netherlands Mark Rutte and government of India in New Delhi. This cooperation between the two countries in the vaccine manufacturing segment is expected to result in large scale production of measles-rubella and other needed vaccine in the country. The ‘Make in India’ is a critical initiative for promoting access to health technology beyond the borders of India.

The MoU signed under ‘Make in India’ initiative of government of India will enable the Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL), a central public sector udertaking (PSU) under department of biotechnology, to develop measles – rubella vaccine at its plant at Chola, Bulandshahr in Uttar Pradesh (UP). Translational Vaccinology (Intravacc), a government-based institute of Netherlands will extend technical support for the development of the vaccine.

Under the ‘Make in India’ initiative of the government, BIBCOL has embarked on journey to acquire technology and production capabilities for production of measles-rubella vaccine with the support of department of biotechnology. BIBCOL aim is to produe and supply of high quality polio vaccine and other biologicals. It played a major role in making India ‘polio free’.

“As India has already excelled in polio eradication, the country is aiming its focus on elimination and control of other preventable viral disease through vaccine and save hundreds of thousands of children from the dreaded disease in the country after polio, measles and rubella are regarded as the second most dreaded diseases affecting the Indian population on a larger scale. Through this MoU, we are expecting mutual cooperation between two countries and produce high quality vaccines in India and immunize the country from dreaded diseases,” said Dr. Harshavardhan, minister for science and technology and earth sciences.


<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>



Latest News